Toward the development of defined microbial therapeutics.

Abstract excerpt

The collection of micro-organisms living in the mammalian gastrointestinal tract, termed the gut microbiota, has been shown to have profound impacts on host health and increasingly is regarded as a viable therapeutic target. Clinical studies of fecal microbiota transplantation have demonstrated potential efficacy of microbiota-based therapies for diseases including Clostridioides difficile infections,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clostridium Infections
• Share to Gastrointestinal Microbiome
• Share to Phenotype